Breaking News Instant updates and real-time market news.

ABT

Abbott

$38.73

0.63 (1.65%)

, STJ

St. Jude Medical

$79.67

0.77 (0.98%)

12:41
11/23/16
11/23
12:41
11/23/16
12:41

EU clears Abbott-St. Jude Medical merger, Dow Jones says

The EU has cleared the proposed merger of Abbott (ABT) and St. Jude Medical (STJ) after Abbott agreed to fully divest its Vado business as well as St. Jude's global vessel closure devices business, Dow Jones reports.

ABT

Abbott

$38.73

0.63 (1.65%)

STJ

St. Jude Medical

$79.67

0.77 (0.98%)

ABT Abbott
$38.73

0.63 (1.65%)

10/25/16
RBCM
10/25/16
NO CHANGE
RBCM
Abbott should be bought on recent weakness, says RBC Capital
After Abbott reported slightly stronger than expected Q3 results, RBC Capital analyst Glenn Novarro predicts that the company's 2016 EPS will come in at $2.63, excluding its acquisition of Alere. The analyst thinks that Abbott's EPs can rise to $2.93 in 2018, excluding the Alere deal, driven by lower interest costs and higher synergies. He says that recent weakness in the stock has been caused by issues that are "either transient or can be offset." The analyst keeps a $48 price target and Outperform rating on the stock.
10/20/16
LEER
10/20/16
NO CHANGE
Target $45
LEER
Market Perform
Abbott selloff overdone as long-term fundamentals remain intact, says Leerink
Leerink analyst Danielle Antalffy believes the selloff in Abbott's shares is overdone, as long-term fundamentals remain intact. With another "solid" quarter in hand, despite a weaker than expected Nutritionals performance, the analyst believes the company seems to remain "solidly" on track to deliver improving operational results in 2017, after a year in which it is reshaping the portfolio by acquiring higher-growth assets and shedding slower, lower-margin businesses. Antalffy reiterates a Market Perform rating on the stock but lowered her price target on the shares to $45 from $48.
10/11/16
COWN
10/11/16
NO CHANGE
Target $85
COWN
Outperform
Cowen says St. Jude advisory common for the industry
While Dear Doctor letters are never a positive, St. Jude Medical's (STJ) medical device advisory relating to a low rate of premature battery depletion in the high voltage portfolio is common in the Cardiac Rhythm Management industry, Cowen analyst Joshua Jennings tells investors in a research note. The analyst sees limited risk to St. Jude's franchise and still expects the takeover by Abbott Laboratories' (ABT) to close by the end of the year. Jennings keeps an Outperform rating on St. Jude shares with an $85 price target. The stock is down 1% to $80.19 in pre-market trading.
09/29/16
BARD
09/29/16
NO CHANGE
BARD
Dexcom, Insulet could be weighed down by competitive concerns, says Baird
Baird analyst Jeff Johnson said that while the FDA approvals announced yesterday for Abbott's (ABT) FreeStyle Libre Pro and Medtronic's (MDT) 670G were largely anticipated, he believes that both approvals came sooner than most expected, as did news that Abbott also recently filed for FDA approval of its consumer Libre system. The approvals could "change the narrative" in diabetes and could weigh on others in the sector in the near-term, most notably Dexcom (DXCM) and Insulet (PODD), Johnson tells investors. He keeps Neutral ratings on both and maintains an Overweight rating on Tandem Diabetes (TNDM), citing valuation for the difference.
STJ St. Jude Medical
$79.67

0.77 (0.98%)

09/19/16
JEFF
09/19/16
NO CHANGE
Target $48
JEFF
Buy
Abbott unit sale does not impact Alere transaction, says Jefferies
Jefferies analyst Jeffrey Holford believes Abbott's (ABT) sale of its Medical Optics business to Johnson & Johnson (JNJ) does not imply an increased probability that the Alere (ALR) deal will close. After speaking to Abbott management, Holford thinks the proceeds from the sale are more likely to be targeted towards the St. Jude Medical (STJ) acquisition. He believes that deal has a higher probability of closing than Alere. Holford has a Buy rating on Abbott with a $48 price target.
09/08/16
PIPR
09/08/16
NO CHANGE
Target $82
PIPR
Neutral
Piper sees little reason to believe St. Jude deal will not close
Piper Jaffray analyst Brooks West says cybersecurity expert Mark Lanterman during a conference call yesterday refuted security claims by MedSec and Muddy Waters against St. Jude Medical's (STJ) pacemakers, defibrillators and Merlin monitoring system. Lanterman stated that there is "not much meat on the bone" to the MedSec claims and the quality of the analysis, West tells investors in a research note. He notes that Abbott (ABT) yesterday at a competitor conference earlier stated the St. Jude acquisition was progressing toward a close before year-end. The analyst sees little reason to believe the transaction will not close in the planned timeframe. West reiterates a Neutral rating on St. Jude.
08/29/16
FBCO
08/29/16
NO CHANGE
FBCO
St. Jude Medical can fix security deficiencies, says Credit Suisse
After speaking with "a developer of software used in drugs/devices" about Muddy Waters' security concerns regarding St. Jude's CRM system, Credit Suisse analyst Matthew Keeler says the consultant believes that the security deficiencies,can be fixed. According to the consultant, the deficiencies can be fixed using a five to ten person team working for about three months, Keeler stated. Keeler does not think that St. Jude's pending acquisition by Abbott (ABT) will be impacted by Muddy Waters' report. He keeps an $81 price target and Neutral rating on St. Jude.

TODAY'S FREE FLY STORIES

CPB

Campbell Soup

$59.00

0.72 (1.24%)

10:21
12/09/16
12/09
10:21
12/09/16
10:21
Options
Campbell Soup calls are stirring »

Campbell Soup calls are…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RH

Restoration Hardware

$32.75

-6.24 (-16.00%)

10:20
12/09/16
12/09
10:20
12/09/16
10:20
Options
Restoration Hardware options active as shares fall on earnings »

Restoration Hardware…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

10:20
12/09/16
12/09
10:20
12/09/16
10:20
General news
Treasury Action: yields remained subdued »

Treasury Action: yields…

CPK

Chesapeake Utilities

$68.55

0.55 (0.81%)

, CNX

CONSOL

$21.16

-0.62 (-2.85%)

10:19
12/09/16
12/09
10:19
12/09/16
10:19
Initiation
On The Fly: Top five analyst initiations »

Catch up on today's…click here.

CPK

Chesapeake Utilities

$68.55

0.55 (0.81%)

CNX

CONSOL

$21.16

-0.62 (-2.85%)

JCI

Johnson Controls

$43.68

0.03 (0.07%)

AMID

American Midstream Partners

$16.95

-0.05 (-0.29%)

BIP

Brookfield Infrastructure

$32.93

0.2499 (0.76%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

ANF

Abercrombie & Fitch

$15.96

-0.28 (-1.72%)

, DLTH

Duluth Holdings

$37.04

3.09 (9.10%)

10:19
12/09/16
12/09
10:19
12/09/16
10:19
Downgrade
On The Fly: Top five analyst downgrades »

Catch up on today's…click here.

ANF

Abercrombie & Fitch

$15.96

-0.28 (-1.72%)

DLTH

Duluth Holdings

$37.04

3.09 (9.10%)

DTEA

DAVIDsTEA

$9.30

0.15 (1.64%)

HLT

Hilton

$26.54

0.295 (1.12%)

HZNP

Horizon Pharma

$15.03

-4.36 (-22.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 14

    Dec

AZN

AstraZeneca

$27.11

0.84 (3.20%)

, ADSK

Autodesk

$81.74

1.4 (1.74%)

10:19
12/09/16
12/09
10:19
12/09/16
10:19
Upgrade
On The Fly: Top five analyst upgrades »

Catch up on today's…click here.

AZN

AstraZeneca

$27.11

0.84 (3.20%)

ADSK

Autodesk

$81.74

1.4 (1.74%)

ETN

Eaton

$69.45

0.47 (0.68%)

FLR

Fluor

$56.77

0.77 (1.38%)

SYY

Sysco

$54.46

0.13 (0.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jan

  • 09

    Jan

  • 16

    Feb

$NYE

NYSE Market Internals

10:16
12/09/16
12/09
10:16
12/09/16
10:16
Technical Analysis
NYSE market internals summary »

Breadth is bullish across…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

10:16
12/09/16
12/09
10:16
12/09/16
10:16
Technical Analysis
NASDAQ market internals summary »

Volume is light for this…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATH

Athene Holding

10:15
12/09/16
12/09
10:15
12/09/16
10:15
Syndicate
Breaking Syndicate news story on Athene Holding »

Athene Holding indicated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

10:15
12/09/16
12/09
10:15
12/09/16
10:15
General news
FX Action: The dollar »

FX Action: The dollar…

SDRL

Seadrill

$3.72

0.315 (9.26%)

10:14
12/09/16
12/09
10:14
12/09/16
10:14
Options
Seadrill calls active as shares rally »

Seadrill calls active as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VHC

VirnetX

$3.35

0.05 (1.52%)

10:12
12/09/16
12/09
10:12
12/09/16
10:12
Periodicals
Breaking Periodicals news story on VirnetX »

Appeals court affirms…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATH

Athene Holding

10:10
12/09/16
12/09
10:10
12/09/16
10:10
Syndicate
Breaking Syndicate news story on Athene Holding »

Athene Holding indicated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

XLF

Financial Select Sector

$23.63

-0.07 (-0.30%)

10:10
12/09/16
12/09
10:10
12/09/16
10:10
Options
$15.9M premium block in SPDR Financials »

$15.9M premium block in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:10
12/09/16
12/09
10:10
12/09/16
10:10
General news
U.S. December consumer sentiment surged 4.2 points to 98.0 in preliminary »

U.S. December consumer…

TEX

Terex

$32.28

-0.06 (-0.19%)

10:09
12/09/16
12/09
10:09
12/09/16
10:09
Upgrade
Terex rating change  »

Terex upgraded to Mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

AZN

AstraZeneca

$27.09

0.82 (3.12%)

10:08
12/09/16
12/09
10:08
12/09/16
10:08
Hot Stocks
FDA accepts BLA for AstraZeneca's durvalumab for bladder cancer »

AstraZeneca and its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Feb

KO

Coca-Cola

$41.82

0.835 (2.04%)

10:04
12/09/16
12/09
10:04
12/09/16
10:04
Technical Analysis
Coca-Cola tests downtrend resistance »

The stock was last at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

10:01
12/09/16
12/09
10:01
12/09/16
10:01
General news
Wholesale Trade Inventories data reported »

October Wholesale Trade…

10:01
12/09/16
12/09
10:01
12/09/16
10:01
General news
Consumer Sentiment Index data reported »

Consumer Sentiment Index…

LVS

Las Vegas Sands

$56.77

2.1 (3.84%)

10:00
12/09/16
12/09
10:00
12/09/16
10:00
Options
Sweep call buyer in LVS »

Sweep call buyer in LVS.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATH

Athene Holding

10:00
12/09/16
12/09
10:00
12/09/16
10:00
Syndicate
Breaking Syndicate news story on Athene Holding »

Athene Holding indicated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

CFX

Colfax

$39.53

0.25 (0.64%)

10:00
12/09/16
12/09
10:00
12/09/16
10:00
Options
Colfax Dec 40 calls trade for 65 and 70c »

Colfax Dec 40 calls trade…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAL

American Airlines

$48.05

-0.6 (-1.23%)

, BIIB

Biogen

$289.54

4.24 (1.49%)

09:55
12/09/16
12/09
09:55
12/09/16
09:55
Options
Early notable gainers among liquid option names on December 9th »

Notable gainers among…

AAL

American Airlines

$48.05

-0.6 (-1.23%)

BIIB

Biogen

$289.54

4.24 (1.49%)

UAL

United Continental

$75.65

2.91 (4.00%)

AVGO

Broadcom

$170.71

2.16 (1.28%)

AGN

Allergan

$193.38

4.91 (2.61%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:55
12/09/16
12/09
09:55
12/09/16
09:55
Conference/Events
JPMorgan aerospace & defense analyst holds an analyst/industry conference call »

Aerospace & Defense…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.